CPDC is actively seeking direct Seed and Series A investments, in-licensing and collaboration opportunities in the radiopharmaceutical space.

As dedicated partners, we bring sector expertise and a robust network to collaborate with management teams, enhancing value and advancing the impact of radiopharmaceutical-focused innovation.

If you are developing a radiopharmaceutical therapeutic, diagnostic or related enabling technology, please reach out to us.

Send us an email including your non-confidential summary to partnering@cpdc.ca